We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
iShares Russell Top 200 Growth ETF
IWY
$16.6B
| $2.18M | 0.01% |
14,287
-1,223
| -8% | -$193K |
|
727
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.26B
| $2.18M | 0.01% |
98,727
+49,405
| +100% | +$1.12M |
|
728
BlackRock Credit Allocation Income Trust
BTZ
$956M
| $2.17M | 0.01% |
143,214
+1,648
| +1% | +$25.6K |
|
729
RingCentral
RNG
$5.28B
| $2.15M | 0.01% |
9,874
+458
| +5% | +$116K |
|
730
National Grid
NGG
$81.3B
| $2.14M | 0.01% |
40,640
+7,275
| +22% | +$417K |
|
731
Ross Stores
ROST
$81.9B
| $2.12M | 0.01% |
19,472
+914
| +5% | +$110K |
|
|
DSL
732
DoubleLine Income Solutions Fund
DSL
$1.24B
| $2.12M | 0.01% |
119,147
+59,754
| +101% | +$1.07M |
|
733
NetApp
NTAP
$37.2B
| $2.12M | 0.01% |
23,571
+650
| +3% | +$54.9K |
|
734
Spotify
SPOT
$100B
| $2.11M | 0.01% |
9,382
+6,308
| +205% | +$1.49M |
|
735
First Trust Financials AlphaDEX Fund
FXO
$1.14B
| $2.1M | 0.01% |
47,559
+616
| +1% | +$27.2K |
|
736
Aurinia Pharmaceuticals
AUPH
$2.11B
| $2.07M | 0.01% |
93,585
+500
| +0.5% | +$7.93K |
|
737
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$742M
| $2.07M | 0.01% |
32,156
+1,942
| +6% | +$127K |
|
|
738
Neurocrine Biosciences
NBIX
$16.6B
| $2.05M | 0.01% |
21,421
-599,300
| -97% | -$56.6M |
|
739
Millicom
TIGO
$16.3B
| $2.05M | 0.01% |
56,655
+8,155
| +17% | +$314K |
|
740
Zimmer Biomet
ZBH
$18.4B
| $2.05M | 0.01% |
14,420
+1,433
| +11% | +$211K |
|
741
Boston Scientific
BSX
$71.5B
| $2.04M | 0.01% |
47,029
+12,069
| +35% | +$534K |
|
742
Bain Capital Specialty
BCSF
$850M
| $2.04M | 0.01% |
137,316
+85,189
| +163% | +$1.29M |
|
743
Airbnb
ABNB
$107B
| $2.02M | 0.01% |
12,074
+3,170
| +36% | +$484K |
|
744
Clearway Energy Class C
CWEN
$6.7B
| $2.02M | 0.01% |
66,886
+10,173
| +18% | +$303K |
|
745
Synopsys
SNPS
$79.7B
| $2.02M | 0.01% |
6,758
+764
| +13% | +$232K |
|
746
KraneShares Global Carbon Strategy ETF
KRBN
$143M
| $2.02M | 0.01% |
49,150
+47,150
| +2,358% | +$1.78M |
|
747
Global X Silver Miners ETF NEW
SIL
$4.75B
| $2.02M | 0.01% |
57,532
+7,975
| +16% | +$317K |
|
748
iShares US Industrials ETF
IYJ
$2.02B
| $2.02M | 0.01% |
18,829
-113
| -0.6% | -$12.7K |
|
749
iShares Core S&P US Value ETF
IUSV
$27.7B
| $2M | 0.01% |
28,202
+10,321
| +58% | +$750K |
|
750
Schwab US Large- Cap ETF
SCHX
$74.5B
| $2M | 0.01% |
115,200
+16,590
| +17% | +$296K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.